FRQ Stock Overview
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Singapore Paincare Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.15 |
| 52 Week High | S$0.21 |
| 52 Week Low | S$0.14 |
| Beta | 0.26 |
| 1 Month Change | -5.00% |
| 3 Month Change | -0.65% |
| 1 Year Change | -25.85% |
| 3 Year Change | -23.23% |
| 5 Year Change | n/a |
| Change since IPO | -27.62% |
Recent News & Updates
Recent updates
Shareholder Returns
| FRQ | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -4.4% | 0.5% | 0.05% |
| 1Y | -25.9% | -24.0% | -5.9% |
Return vs Industry: FRQ underperformed the SG Healthcare industry which returned -22.9% over the past year.
Return vs Market: FRQ underperformed the SG Market which returned -5.4% over the past year.
Price Volatility
| FRQ volatility | |
|---|---|
| FRQ Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.9% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 15.3% |
| 10% least volatile stocks in SG Market | 2.2% |
Stable Share Price: FRQ has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine FRQ's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 77 | Bernard Lee | www.sgpaincareholdings.com |
Singapore Paincare Holdings Limited, an investment holding company, operates medical clinics in Singapore. It offers pain care services for the treatment of patients suffering from acute and chronic pain, including minimally invasive procedures, cancer pain therapy, pharmacotherapy, and cognitive behavioural therapy, as well as neck pain, lower, spinal stenosis, osteoarthritis, fibromyalgia, frozen shoulder, plantar fasciitis, and tennis elbow pain conditions; and primary care and other services comprising general medical consultations, management of chronic and acute conditions, and dermatology services. The company also offers myofascial pain injections, platelet rich plasma, neuroplasty, necleoplasty, radio frequency ablation, intrathecal pump implants, pulsed radio frequency, spinal cord stimulator, ketamine therapy, and endoscopic laser decompression services.
Singapore Paincare Holdings Limited Fundamentals Summary
| FRQ fundamental statistics | |
|---|---|
| Market cap | S$25.99m |
| Earnings (TTM) | -S$336.00k |
| Revenue (TTM) | S$24.74m |
1.1x
P/S Ratio-77.4x
P/E RatioIs FRQ overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FRQ income statement (TTM) | |
|---|---|
| Revenue | S$24.74m |
| Cost of Revenue | S$15.43m |
| Gross Profit | S$9.32m |
| Other Expenses | S$9.66m |
| Earnings | -S$336.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.002 |
| Gross Margin | 37.66% |
| Net Profit Margin | -1.36% |
| Debt/Equity Ratio | 21.1% |
How did FRQ perform over the long term?
See historical performance and comparison